Novo Nordisk A/S | NOVOB - Net Income


Novo Nordisk reported DKK26.89B in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Bausch Health Companies USD -112M 291M Dec/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
Merck USD 2.96B 2.82B Dec/2025
Novartis USD 2.41B 1.52B Dec/2025
Novo Nordisk DKK 26.89B 388M Dec/2025
Novo Nordisk DKK 4.03B 25.01B Jun/2025
Pacira USD 1.64M 3.8M Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
Supernus Pharmaceuticals USD -45.12M 67.62M Sep/2025